Tesamorelin
- Createtime： 2026-06-04
- Updatetime： 2026-06-01
Product Details
| useage |
Only used in lab research for GHRH pathway, lipid metabolism and peptide drug development
|
| deliveryInfo |
|
| appearance |
white fine powder
|
| aliasen |
|
| supplyCapacity |
100G/Day
|
| harbor |
Hong Kong
|
| minorder |
1G
|
| Payment method |
Alibaba, PayPal, USDT, bank card, Western Union remittance
|
| Delivery date |
7 days
|
| Whatsapp |
86 131 7158 8872
|
1. Basic Product Information
Product Name: Tesamorelin
Synonyms: D06655, Tesamorel, Adipotide/FTTP, Tesamorelin Acetate, USAN-Tesamorelin, MFCD06199102
CAS No.：218949-48-5
EINECS: 603-809-2
Molecular Formula:
\(\boldsymbol{C_{221}H_{366}N_{72}O_{67}S}\)
Purity: ≥99% (HPLC & SDS-PAGE certified, complying with USP/EP/BP pharmacopoeia standards)
Packing Specification: 10 vials per box, sterile lyophilized powder in individual glass vials
2. Physical & Chemical Characteristics
Tesamorelin is a synthetic modified polypeptide consisting of 44 amino acids, presented as white to off-white sterile freeze-dried solid powder.
- Solubility: Freely soluble in sterile water for injection and weak-acid aqueous buffer; practically insoluble in ethanol, acetone and other organic solvents.
- Modification feature: Modified with trans-3-hexenoic acid at the N-terminus to resist enzymatic hydrolysis and prolong biological half-life compared with endogenous natural GHRH.
- Molecular Weight: About 5135.86 Da.
3. Product Application (Research Only)
This compound is exclusively for laboratory scientific research use, prohibited for human clinical injection or medication:
- Pharmacological mechanism research: Research on growth hormone-releasing hormone (GHRH) receptor agonist signaling pathway, in-vitro cell-based target drug screening;
- Preclinical metabolic study: Experimental research for visceral fat metabolism, pharmacodynamic test of HIV-associated lipodystrophy disease model;
- Pharmaceutical development: Raw material research and formulation exploration for novel peptide drugs following USP/EP/BP specification requirements.
4. Storage & Transportation Requirements
- Long-term storage: Sealed storage at -20℃ under dark and dry environment; avoid repeated freeze-thaw operations after powder reconstitution.
- Transit: Cold-chain shipping with ice packs to maintain polypeptide biological activity during delivery.
5. Packaging Advantage
Individually packaged sterile glass vials effectively prevent cross-contamination, convenient for precise aliquoting and weighing during laboratory testing; uniform carton packing of 10 vials facilitates inventory management and international logistics.
